comparemela.com

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Free Report) – Analysts at Cantor Fitzgerald issued their FY2024 earnings per share estimates for shares of Longboard Pharmaceuticals in a research report issued to clients and investors on Tuesday, July 11th. Cantor Fitzgerald analyst C. Duncan expects that the company will earn ($2.11) per share for the year. The […]

Related Keywords

Cantor Fitzgerald ,Longboard Pharmaceuticals Stock ,Blackrock Inc ,Farallon Capital Management ,News Ratings For Longboard Pharmaceuticals Daily ,Nasdaq ,Longboard Pharmaceuticals Inc ,Longboard Pharmaceuticals ,Asset Management Inc ,Free Report ,Longboard Pharmaceutical ,Get Free Report ,Capital Management ,Management Inc ,Longboard Pharmaceuticals Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.